President launches TrumpRx platform aimed at lowering prescription drug prices Image By HPN Staff Key Points President Trump introduced an online portal offering pre-negotiated, most-favored-nation pricing on 43 brand-name prescription drugs, with consumers accessing discounted prices via pharmacy coupons. The platform claims discounts of 33% to 93%, including reductions on high-cost GLP-1 medications to as low as $149 per month, aiming to align U.S. prices more closely with those in other developed countries. The initiative ties into Trump’s “Great Healthcare Plan,” a market-focused framework to lower drug costs and increase transparency, launched amid widespread public dissatisfaction with U.S. healthcare affordability. President Donald Trump has unveiled a new online platform, TrumpRx, that he says will give Americans access to “dramatically” lower prices on certain prescription drugs. The launch follows months of negotiations between the administration and pharmaceutical manufacturers to secure most-favored-nation pricing agreements. The White House said the effort is intended to bring U.S. drug prices more in line with those paid in other developed countries. The website lists upfront, out-of-pocket prices for common brand-name medications not typically covered by insurance. Consumers access the pre-negotiated prices at their local pharmacy via coupons provided through the site. Why it matters At launch, the TrumpRX website featured 43 prescription medications, including treatments for infertility, asthma and weight loss. Administration officials said more drugs will be added over time. Among the highlighted drugs are GLP-1 medications, which the administration described as among the highest-spend drug categories in the United States. The administration said some of these drugs, such as the Wegovy pill, are being reduced from original list prices that ran into the thousands of dollars per month to new negotiated prices as low as $149 per month. Overall, the platform advertises savings ranging from 33% to 93% off the list price. “We were essentially subsidizing the entire world and subsidizing by hundreds of billions of dollars every year,” Trump added. “The United States is just 4 percent of the world’s population and consumes only 13 percent of all prescription drugs. Yet pharmaceutical companies have been making 75 percent from these drugs. Think of it. Seventy-five percent of the money they made came from the United States.” Some policy groups praised the move as a disruption to the traditional pricing system. Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, applauded the effort, calling it a “shake up” to the system that is “bypassing the drug middlemen.” The bigger picture Public dissatisfaction with the U.S. health care system remains high. A recent Gallup poll found just 16% of Americans are satisfied with health care costs, while 23% said the system is “in a state of crisis,” a record high. Earlier this year, Trump unveiled the “Great Healthcare Plan,” a four-part framework aimed at lowering drug prices, reducing insurance premiums, holding insurers accountable and expanding price transparency. The plan outlines broad goals rather than detailed legislative language. As part of the TrumpRx rollout, Trump urged Congress to codify the Great Healthcare Plan. The administration framed the initiative as a market-oriented approach to give consumers more direct control over costs, a step it says will help address concerns about affordability that continue to trouble voters. SUGGESTED STORIES Federal agency launches $2 million AI challenge to support caregivers Health and Human Services Secretary Robert F. Kennedy Jr. announced federal backing this week for the Caregiver Artificial Intelligence Prize Competition — a new national challenge aimed at easing the growing burden on the more than 70 million Americans serving as caregiver Read more Beverage industry launches transparency initiative Want to know what’s in your soft drink? America’s beverage industry is taking the initiative on ingredient transparency by launching a new website they say will enable consumers to easily access information about what is in their favorite drinks. The American Beverage Association ( Read more Colorado drug price cap raises concerns over access and innovation Colorado’s Prescription Drug Affordability Review Board (PDAB) last week became the first state to set a price cap on a specific prescription drug, limiting a 50-milligram dose of Enbrel, used to treat rheumatoid arthritis, to $600. Since its introduction in 1998, Enbrel’s Read more
Federal agency launches $2 million AI challenge to support caregivers Health and Human Services Secretary Robert F. Kennedy Jr. announced federal backing this week for the Caregiver Artificial Intelligence Prize Competition — a new national challenge aimed at easing the growing burden on the more than 70 million Americans serving as caregiver Read more
Beverage industry launches transparency initiative Want to know what’s in your soft drink? America’s beverage industry is taking the initiative on ingredient transparency by launching a new website they say will enable consumers to easily access information about what is in their favorite drinks. The American Beverage Association ( Read more
Colorado drug price cap raises concerns over access and innovation Colorado’s Prescription Drug Affordability Review Board (PDAB) last week became the first state to set a price cap on a specific prescription drug, limiting a 50-milligram dose of Enbrel, used to treat rheumatoid arthritis, to $600. Since its introduction in 1998, Enbrel’s Read more
